New pill could tame severe eczema Flare-Ups
NCT ID NCT07180511
Summary
This study is testing whether an oral tablet called QY201 can help adults with moderate to severe atopic dermatitis, also known as eczema. Researchers will compare the pill to a placebo (a dummy pill) to see if it reduces skin inflammation and itching over 16 weeks. The trial is for people whose eczema hasn't been well controlled with standard creams or other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
EnitiateBioPharma
Hangzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.